Patents by Inventor Margaret H. Dugan

Margaret H. Dugan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination therapy (temozolomide and ?-IFN) for advanced cancer
    Patent number: 7294332
    Abstract: There is disclosed a method for treating advanced cancer in patients in need of such treating. Temozolomide and alpha interferon are administered in combination in amounts sufficient to achieve a clinical response.
    Type: Grant
    Filed: April 26, 2002
    Date of Patent: November 13, 2007
    Assignee: Schering Corporation
    Inventor: Margaret H. Dugan
  • Combination therapy (temozolomide and alpha-IFN) for advanced cancer
    Publication number: 20020172662
    Abstract: There is disclosed a method for treating advanced cancer in patients in need of such treating. Temozolomide and alpha interferon are administered in combination in amounts sufficient to achieve a clinical response.
    Type: Application
    Filed: April 26, 2002
    Publication date: November 21, 2002
    Inventor: Margaret H. Dugan
  • Method for treating pediatric high grade astrocytoma including brain stem glioma
    Patent number: 5942247
    Abstract: There is disclosed a method for treating high grade astrocytoma, especially brain stem glioma, in a child by administering to a child in need of such treating an amount of temozolomide sufficient to achieve a clinical response. Preferred dosing schedules are provided.
    Type: Grant
    Filed: July 29, 1997
    Date of Patent: August 24, 1999
    Assignee: Schering Corporation
    Inventor: Margaret H. Dugan
  • Cancer treatment with temozolomide
    Patent number: 5939098
    Abstract: There is disclosed a method for treating cancer in a patient in need of such treating comprising administering temozolomide in an amount sufficient to achieve a clinical response wherein the temozolomide is administered more than once per day. Preferred specific dosing schedules are provided.
    Type: Grant
    Filed: July 29, 1997
    Date of Patent: August 17, 1999
    Assignee: Schering Corporation
    Inventors: Pascale Reidenberg, Margaret H. Dugan
  • Combination therapy for advanced cancer
    Patent number: 5824346
    Abstract: There is disclosed a method for treating advanced cancer in patients in need of such treating. Temozolomide and cisplatin are administered in combination in amounts sufficient to achieve a clinical response.
    Type: Grant
    Filed: August 22, 1996
    Date of Patent: October 20, 1998
    Assignee: Schering Corporation
    Inventor: Margaret H. Dugan